Home › Funds › LITTLE HOUSE CAPITAL LLC › VRTX

LITTLE HOUSE CAPITAL LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

LITTLE HOUSE CAPITAL LLC reported holding 9,574 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 1.12% of its reported portfolio and ranking #27 among its reported holdings. LITTLE HOUSE CAPITAL LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)9.57K sh
Reported value held$5.01M
Portfolio Weight1.12%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LITTLE HOUSE CAPITAL LLC's VRTX position evolved

LITTLE HOUSE CAPITAL LLC first disclosed a stake in VRTX in Q3 2023 at 1,461 shares (US$508K). The position peaked in Q3 2026 at 9,574 shares, worth US$5.0M. Across 13 filings, LITTLE HOUSE CAPITAL LLC increased the stake 9 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 9,574 shares valued at US$5.0M — an increase of 440 shares quarter over quarter.. Notable position changes include a 59% increase in Q4 2023 (shares rose 2% over the following quarter), a 38% increase in Q3 2024 (shares fell 13% over the following quarter), a 67% increase in Q3 2025 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.46K $508.05K New
Q4 2023 2.32K $943.99K Add
Q1 2024 2.50K $1.04M Add
Q2 2024 2.69K $1.26M Add
Q3 2024 3.72K $1.73M Add
Q4 2024 4.73K $1.91M Add
Q1 2025 6.31K $3.06M Add
Q2 2025 5.83K $2.60M Reduce
Q3 2025 9.76K $3.82M Add
Q4 2025 8.94K $4.05M Reduce
Q1 2026 8.96K $4.00M Hold
Q2 2026 9.13K $4.54M Add
Q3 2026 9.57K $5.01M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has LITTLE HOUSE CAPITAL LLC held VRTX?

LITTLE HOUSE CAPITAL LLC has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LITTLE HOUSE CAPITAL LLC's current position in VRTX?

As of Q3 2026, LITTLE HOUSE CAPITAL LLC holds 9.57K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $5.01M, representing 1.12% of its reported portfolio and ranking #27.

Has LITTLE HOUSE CAPITAL LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), LITTLE HOUSE CAPITAL LLC increased its position in VRTX. The position peaked in Q3 2026 at 9.57K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.